Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern

Abstract: The ongoing COVID‐19 pandemic and the emergence of new SARS‐CoV‐2 variants of concern (VOCs) requires continued development of effective therapeutics. Recently, we identified high‐affinity neutralizing nanobodies (Nbs) specific for the receptor‐binding domain (RBD) of SARS‐CoV‐2. Taking advantage of detailed epitope mapping, we generate two biparatopic Nbs (bipNbs) targeting a conserved epitope outside and two different epitopes inside the RBD:ACE2 interface. Both bipNbs bind all currently circulating VOCs with high affinities and are capable to neutralize cellular infection with VOC B.1.351 (Beta) and B.1.617.2 (Delta) in vitro. To assess if the bipNbs NM1267 and NM1268 confer protection against SARS‐CoV‐2 infection in vivo, human ACE2 transgenic mice are treated intranasally before infection with a lethal dose of SARS‐CoV‐2 B.1, B.1.351 (Beta) or B.1.617.2 (Delta). Nb‐treated mice show significantly reduced disease progression and increased survival rates. Histopathological analyses further reveal a drastically reduced viral load and inflammatory response in lungs. These data suggest that both bipNbs are broadly active against a variety of emerging SARS‐CoV‐2 VOCs and represent easily applicable drug candidates.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern ; day:20 ; month:12 ; year:2021 ; extent:16
EMBO reports / European Molecular Biology Organization ; (20.12.2021) (gesamt 16)

Urheber
Wagner, Teresa R.
Schnepf, Daniel
Beer, Julius
Ruetalo, Natalia
Klingel, Karin
Kaiser, Philipp D.
Junker, Daniel
Sauter, Martina
Tränkle, Björn
Frecot, Desiree I.
Becker, Matthias D.
Schneiderhan‐Marra, Nicole
Ohnemus, Annette
Schwemmle, Martin
Schindler, Michael
Rothbauer, Ulrich

DOI
10.15252/embr.202153865
URN
urn:nbn:de:101:1-2021122014093137021230
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:21 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

Ähnliche Objekte (12)